Table 1.
Baseline characteristics of the 154 patients who underwent radical prostatectomy.
| Baseline Characteristics | Number of Patients (%) or Median (IQR) |
|---|---|
| Age (years) | 64 (58–66) |
| Gleason score at biopsy | 6: n = 63 (41%) 7: n = 79 (51%) 8: n = 12 (8%) |
| tPSA (ng/mL) | 6.5 (5.0–9.9) |
| fPSA (ng/mL) | 0.9 (0.6–1.2) |
| %fPSA (%) | 12.5 (10.5–16.1) |
| %p2PSA (%) | 13.8 (10.2–19.7) |
| PHI | 42.15 (33–56) |
| PCA3 score | 45 (23–87) |
| T2 score | 34 (5–138) |
Abbreviations: IQR: interquartile range; PCA3: prostate cancer gene 3; PSA: prostate-specific antigen; tPSA: total serum PSA; fPSA: free serum PSA; %fPSA: fPSA-to-tPSA ratio; %p2PSA: p2PSA-to-tPSA ratio; PHI: Prostate Health Index; SD: standard deviation; T2: TMPRSS2:ERG fusion gene.